Randomized Phase Iii Trial of Folfox Versus Xelox As Adjuvant Chemotherapy in Patients with Early-Stage Colorectal Adenocarcinoma.

Dimitrios G. Pectasides,George Papaxoinis,Ioannis Xanthakis,George Kouvatseas,Vassiliki Kotoula,Nikolaos Xiros,Epaminondas Samantas,Pavlos Papakostas,George Klouvas,Ioannis I. Varthalitis,George E. Pentheroudakis,George Fountzilas,Dimitris Bafaloukos

Journal of clinical oncology（2014）

引用 3|浏览60

暂无评分

摘要

3617 Background: The aim of the trial was to compare two active adjuvant chemotherapy regimens in patients with early stage colorectal cancer (CRC). Methods: Patients were assigned to oxaliplatin 8...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要